Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$233.08 - $265.59 $6,992 - $7,967
-30 Reduced 3.5%
826 $204,000
Q2 2023

Aug 11, 2023

SELL
$224.99 - $256.14 $20,249 - $23,052
-90 Reduced 9.51%
856 $205,000
Q1 2023

May 12, 2023

SELL
$239.75 - $277.0 $23,255 - $26,869
-97 Reduced 9.3%
946 $238,000
Q4 2022

Feb 09, 2023

BUY
$241.42 - $282.29 $35,971 - $42,061
149 Added 16.67%
1,043 $276,000
Q3 2022

Nov 10, 2022

SELL
$247.06 - $1507.4 $16,305 - $99,488
-66 Reduced 6.88%
894 $221,000
Q2 2022

Aug 03, 2022

BUY
$237.11 - $299.66 $7,350 - $9,289
31 Added 3.34%
960 $243,000
Q1 2022

May 10, 2022

SELL
$257.27 - $315.76 $13,892 - $17,051
-54 Reduced 5.49%
929 $273,000
Q4 2021

Feb 08, 2022

SELL
$292.08 - $329.01 $5,841 - $6,580
-20 Reduced 1.99%
983 $323,000
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $21,776 - $26,594
-80 Reduced 7.39%
1,003 $305,000
Q2 2021

Aug 06, 2021

SELL
$225.08 - $271.69 $13,504 - $16,301
-60 Reduced 5.25%
1,083 $333,000
Q1 2021

Apr 27, 2021

BUY
$212.38 - $245.9 $22,937 - $26,557
108 Added 10.43%
1,143 $257,000
Q3 2020

Oct 13, 2020

SELL
$177.16 - $215.33 $13,287 - $16,149
-75 Reduced 6.76%
1,035 $234,000
Q2 2020

Aug 05, 2020

SELL
$128.7 - $176.83 $82,368 - $113,171
-640 Reduced 36.57%
1,110 $229,000
Q1 2020

May 06, 2020

SELL
$121.39 - $169.05 $23,671 - $32,964
-195 Reduced 10.03%
1,750 $242,000
Q4 2019

Feb 05, 2020

SELL
$133.47 - $153.48 $63,398 - $72,903
-475 Reduced 19.63%
1,945 $317,000
Q3 2019

Oct 22, 2019

SELL
$135.4 - $146.47 $17,602 - $19,041
-130 Reduced 5.1%
2,420 $335,000
Q1 2019

May 13, 2019

SELL
$97.62 - $132.29 $19,524 - $26,458
-200 Reduced 7.27%
2,550 $337,000
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $260,837 - $301,235
2,750 New
2,750 $306,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Miramar Capital, LLC Portfolio

Follow Miramar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miramar Capital, LLC with notifications on news.